nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—Topoisomerase Inhibitors—Mitoxantrone—multiple sclerosis	0.58	1	CiPCiCtD
Daunorubicin—NR5A1—Cladribine—multiple sclerosis	0.134	0.414	CbGbCtD
Daunorubicin—XDH—Azathioprine—multiple sclerosis	0.0297	0.0919	CbGbCtD
Daunorubicin—TOP2A—Mitoxantrone—multiple sclerosis	0.0198	0.0614	CbGbCtD
Daunorubicin—CYP1B1—Mitoxantrone—multiple sclerosis	0.0155	0.0479	CbGbCtD
Daunorubicin—SLC22A2—Cladribine—multiple sclerosis	0.0137	0.0423	CbGbCtD
Daunorubicin—ABCC10—Methotrexate—multiple sclerosis	0.0119	0.0367	CbGbCtD
Daunorubicin—ABCC1—Mitoxantrone—multiple sclerosis	0.011	0.034	CbGbCtD
Daunorubicin—ABCG2—Cladribine—multiple sclerosis	0.0101	0.0312	CbGbCtD
Daunorubicin—ABCB11—Dexamethasone—multiple sclerosis	0.00802	0.0248	CbGbCtD
Daunorubicin—CYP1B1—Dexamethasone—multiple sclerosis	0.00802	0.0248	CbGbCtD
Daunorubicin—ABCG2—Mitoxantrone—multiple sclerosis	0.00735	0.0228	CbGbCtD
Daunorubicin—ABCC1—Methotrexate—multiple sclerosis	0.00458	0.0142	CbGbCtD
Daunorubicin—ABCC2—Dexamethasone—multiple sclerosis	0.00422	0.0131	CbGbCtD
Daunorubicin—ABCG2—Dexamethasone—multiple sclerosis	0.00381	0.0118	CbGbCtD
Daunorubicin—ABCB1—Methylprednisolone—multiple sclerosis	0.00363	0.0113	CbGbCtD
Daunorubicin—CYP1A1—Dexamethasone—multiple sclerosis	0.00352	0.0109	CbGbCtD
Daunorubicin—ABCC2—Methotrexate—multiple sclerosis	0.00339	0.0105	CbGbCtD
Daunorubicin—CYP3A4—Fingolimod—multiple sclerosis	0.00338	0.0105	CbGbCtD
Daunorubicin—ABCG2—Methotrexate—multiple sclerosis	0.00306	0.00949	CbGbCtD
Daunorubicin—ABCB1—Mitoxantrone—multiple sclerosis	0.00265	0.00821	CbGbCtD
Daunorubicin—ABCB1—Betamethasone—multiple sclerosis	0.00236	0.00732	CbGbCtD
Daunorubicin—ABCB1—Prednisolone—multiple sclerosis	0.00233	0.00722	CbGbCtD
Daunorubicin—ABCB1—Prednisone—multiple sclerosis	0.0022	0.00682	CbGbCtD
Daunorubicin—CYP3A4—Methylprednisolone—multiple sclerosis	0.00218	0.00674	CbGbCtD
Daunorubicin—CYP3A5—Dexamethasone—multiple sclerosis	0.00211	0.00654	CbGbCtD
Daunorubicin—CYP3A4—Triamcinolone—multiple sclerosis	0.00165	0.00511	CbGbCtD
Daunorubicin—CYP3A4—Mitoxantrone—multiple sclerosis	0.00159	0.00492	CbGbCtD
Daunorubicin—CYP3A4—Betamethasone—multiple sclerosis	0.00142	0.00439	CbGbCtD
Daunorubicin—CYP3A4—Prednisolone—multiple sclerosis	0.0014	0.00433	CbGbCtD
Daunorubicin—ABCB1—Dexamethasone—multiple sclerosis	0.00137	0.00426	CbGbCtD
Daunorubicin—CYP3A4—Prednisone—multiple sclerosis	0.00132	0.00409	CbGbCtD
Daunorubicin—ABCB1—Methotrexate—multiple sclerosis	0.0011	0.00342	CbGbCtD
Daunorubicin—CYP3A4—Dexamethasone—multiple sclerosis	0.000823	0.00255	CbGbCtD
Daunorubicin—NR5A1—brainstem—multiple sclerosis	0.000745	0.0639	CbGeAlD
Daunorubicin—ABCC6—retina—multiple sclerosis	0.000504	0.0433	CbGeAlD
Daunorubicin—YWHAG—retina—multiple sclerosis	0.000475	0.0407	CbGeAlD
Daunorubicin—TOP2B—brainstem—multiple sclerosis	0.000474	0.0407	CbGeAlD
Daunorubicin—TOP2B—retina—multiple sclerosis	0.000458	0.0393	CbGeAlD
Daunorubicin—NR5A1—nervous system—multiple sclerosis	0.00039	0.0335	CbGeAlD
Daunorubicin—NR5A1—central nervous system—multiple sclerosis	0.000376	0.0322	CbGeAlD
Daunorubicin—NR5A1—cerebellum—multiple sclerosis	0.000367	0.0315	CbGeAlD
Daunorubicin—YWHAG—medulla oblongata—multiple sclerosis	0.000343	0.0294	CbGeAlD
Daunorubicin—TOP2B—medulla oblongata—multiple sclerosis	0.000331	0.0284	CbGeAlD
Daunorubicin—YWHAG—midbrain—multiple sclerosis	0.000314	0.0269	CbGeAlD
Daunorubicin—YWHAG—spinal cord—multiple sclerosis	0.000306	0.0263	CbGeAlD
Daunorubicin—TOP2B—midbrain—multiple sclerosis	0.000302	0.0259	CbGeAlD
Daunorubicin—NR5A1—brain—multiple sclerosis	0.000298	0.0256	CbGeAlD
Daunorubicin—TOP2B—spinal cord—multiple sclerosis	0.000295	0.0253	CbGeAlD
Daunorubicin—TOP2A—Floxuridine—Cladribine—multiple sclerosis	0.000282	0.378	CbGdCrCtD
Daunorubicin—POR—medulla oblongata—multiple sclerosis	0.000261	0.0224	CbGeAlD
Daunorubicin—YWHAG—nervous system—multiple sclerosis	0.000258	0.0221	CbGeAlD
Daunorubicin—TOP2B—nervous system—multiple sclerosis	0.000249	0.0213	CbGeAlD
Daunorubicin—YWHAG—central nervous system—multiple sclerosis	0.000248	0.0213	CbGeAlD
Daunorubicin—YWHAG—cerebellum—multiple sclerosis	0.000243	0.0208	CbGeAlD
Daunorubicin—TOP2B—central nervous system—multiple sclerosis	0.000239	0.0205	CbGeAlD
Daunorubicin—POR—midbrain—multiple sclerosis	0.000239	0.0205	CbGeAlD
Daunorubicin—TOP2B—cerebellum—multiple sclerosis	0.000234	0.0201	CbGeAlD
Daunorubicin—POR—spinal cord—multiple sclerosis	0.000233	0.02	CbGeAlD
Daunorubicin—ABCC10—medulla oblongata—multiple sclerosis	0.000207	0.0178	CbGeAlD
Daunorubicin—YWHAG—brain—multiple sclerosis	0.000197	0.0169	CbGeAlD
Daunorubicin—TOP2A—Clofarabine—Cladribine—multiple sclerosis	0.000197	0.265	CbGdCrCtD
Daunorubicin—TOP2B—brain—multiple sclerosis	0.00019	0.0163	CbGeAlD
Daunorubicin—ABCC10—midbrain—multiple sclerosis	0.000189	0.0162	CbGeAlD
Daunorubicin—ABCC10—spinal cord—multiple sclerosis	0.000185	0.0158	CbGeAlD
Daunorubicin—POR—cerebellum—multiple sclerosis	0.000185	0.0158	CbGeAlD
Daunorubicin—POR—brain—multiple sclerosis	0.00015	0.0129	CbGeAlD
Daunorubicin—ABCC10—cerebellum—multiple sclerosis	0.000146	0.0126	CbGeAlD
Daunorubicin—CYP1B1—nervous system—multiple sclerosis	0.000122	0.0105	CbGeAlD
Daunorubicin—ABCG2—medulla oblongata—multiple sclerosis	0.000121	0.0104	CbGeAlD
Daunorubicin—TOP2A—Azacitidine—Cladribine—multiple sclerosis	0.00012	0.161	CbGdCrCtD
Daunorubicin—ABCC10—brain—multiple sclerosis	0.000119	0.0102	CbGeAlD
Daunorubicin—CYP1B1—central nervous system—multiple sclerosis	0.000118	0.0101	CbGeAlD
Daunorubicin—CYP1B1—cerebellum—multiple sclerosis	0.000115	0.00988	CbGeAlD
Daunorubicin—ABCG2—midbrain—multiple sclerosis	0.000111	0.00951	CbGeAlD
Daunorubicin—ABCG2—spinal cord—multiple sclerosis	0.000108	0.00928	CbGeAlD
Daunorubicin—ABCC1—cerebellum—multiple sclerosis	0.000104	0.00888	CbGeAlD
Daunorubicin—CYP1B1—brain—multiple sclerosis	9.35e-05	0.00802	CbGeAlD
Daunorubicin—CYP1A1—nervous system—multiple sclerosis	8.65e-05	0.00742	CbGeAlD
Daunorubicin—ABCG2—cerebellum—multiple sclerosis	8.57e-05	0.00735	CbGeAlD
Daunorubicin—ABCC1—brain—multiple sclerosis	8.41e-05	0.00722	CbGeAlD
Daunorubicin—CYP1A1—central nervous system—multiple sclerosis	8.33e-05	0.00714	CbGeAlD
Daunorubicin—ABCB1—retina—multiple sclerosis	8.27e-05	0.0071	CbGeAlD
Daunorubicin—TOP2A—Methyltestosterone—Prednisone—multiple sclerosis	7.37e-05	0.0989	CbGdCrCtD
Daunorubicin—TOP2A—Methyltestosterone—Prednisolone—multiple sclerosis	7.19e-05	0.0966	CbGdCrCtD
Daunorubicin—ABCG2—brain—multiple sclerosis	6.96e-05	0.00597	CbGeAlD
Daunorubicin—CYP1A1—brain—multiple sclerosis	6.61e-05	0.00567	CbGeAlD
Daunorubicin—CYP3A4—nervous system—multiple sclerosis	6.35e-05	0.00544	CbGeAlD
Daunorubicin—CYP3A4—central nervous system—multiple sclerosis	6.11e-05	0.00524	CbGeAlD
Daunorubicin—ABCB1—medulla oblongata—multiple sclerosis	5.98e-05	0.00513	CbGeAlD
Daunorubicin—ABCB1—midbrain—multiple sclerosis	5.46e-05	0.00469	CbGeAlD
Daunorubicin—ABCB1—spinal cord—multiple sclerosis	5.33e-05	0.00457	CbGeAlD
Daunorubicin—Convulsion—Triamcinolone—multiple sclerosis	4.85e-05	0.000784	CcSEcCtD
Daunorubicin—Tachycardia—Prednisolone—multiple sclerosis	4.85e-05	0.000784	CcSEcCtD
Daunorubicin—Convulsion—Methylprednisolone—multiple sclerosis	4.84e-05	0.000782	CcSEcCtD
Daunorubicin—Hypertension—Triamcinolone—multiple sclerosis	4.84e-05	0.000781	CcSEcCtD
Daunorubicin—Hypertension—Methylprednisolone—multiple sclerosis	4.83e-05	0.00078	CcSEcCtD
Daunorubicin—Urticaria—Mitoxantrone—multiple sclerosis	4.81e-05	0.000778	CcSEcCtD
Daunorubicin—Hyperhidrosis—Prednisolone—multiple sclerosis	4.81e-05	0.000777	CcSEcCtD
Daunorubicin—Abdominal pain—Mitoxantrone—multiple sclerosis	4.79e-05	0.000774	CcSEcCtD
Daunorubicin—Body temperature increased—Mitoxantrone—multiple sclerosis	4.79e-05	0.000774	CcSEcCtD
Daunorubicin—Myalgia—Triamcinolone—multiple sclerosis	4.77e-05	0.000771	CcSEcCtD
Daunorubicin—Vomiting—Azathioprine—multiple sclerosis	4.77e-05	0.00077	CcSEcCtD
Daunorubicin—Myalgia—Methylprednisolone—multiple sclerosis	4.76e-05	0.000769	CcSEcCtD
Daunorubicin—Arthralgia—Methylprednisolone—multiple sclerosis	4.76e-05	0.000769	CcSEcCtD
Daunorubicin—Anxiety—Methylprednisolone—multiple sclerosis	4.74e-05	0.000766	CcSEcCtD
Daunorubicin—Rash—Azathioprine—multiple sclerosis	4.73e-05	0.000764	CcSEcCtD
Daunorubicin—Dermatitis—Azathioprine—multiple sclerosis	4.72e-05	0.000763	CcSEcCtD
Daunorubicin—Depression—Methotrexate—multiple sclerosis	4.72e-05	0.000763	CcSEcCtD
Daunorubicin—Flushing—Prednisone—multiple sclerosis	4.72e-05	0.000763	CcSEcCtD
Daunorubicin—Ill-defined disorder—Betamethasone—multiple sclerosis	4.72e-05	0.000762	CcSEcCtD
Daunorubicin—Ill-defined disorder—Dexamethasone—multiple sclerosis	4.72e-05	0.000762	CcSEcCtD
Daunorubicin—Discomfort—Triamcinolone—multiple sclerosis	4.71e-05	0.000761	CcSEcCtD
Daunorubicin—Discomfort—Methylprednisolone—multiple sclerosis	4.7e-05	0.00076	CcSEcCtD
Daunorubicin—Headache—Azathioprine—multiple sclerosis	4.7e-05	0.000759	CcSEcCtD
Daunorubicin—Dry mouth—Triamcinolone—multiple sclerosis	4.66e-05	0.000754	CcSEcCtD
Daunorubicin—Renal failure—Methotrexate—multiple sclerosis	4.65e-05	0.000752	CcSEcCtD
Daunorubicin—Stomatitis—Methotrexate—multiple sclerosis	4.61e-05	0.000746	CcSEcCtD
Daunorubicin—Conjunctivitis—Methotrexate—multiple sclerosis	4.6e-05	0.000744	CcSEcCtD
Daunorubicin—Confusional state—Methylprednisolone—multiple sclerosis	4.6e-05	0.000743	CcSEcCtD
Daunorubicin—Malaise—Betamethasone—multiple sclerosis	4.58e-05	0.000741	CcSEcCtD
Daunorubicin—Malaise—Dexamethasone—multiple sclerosis	4.58e-05	0.000741	CcSEcCtD
Daunorubicin—Oedema—Triamcinolone—multiple sclerosis	4.57e-05	0.000739	CcSEcCtD
Daunorubicin—Anaphylactic shock—Triamcinolone—multiple sclerosis	4.57e-05	0.000739	CcSEcCtD
Daunorubicin—Anaphylactic shock—Methylprednisolone—multiple sclerosis	4.56e-05	0.000737	CcSEcCtD
Daunorubicin—Syncope—Dexamethasone—multiple sclerosis	4.56e-05	0.000737	CcSEcCtD
Daunorubicin—Syncope—Betamethasone—multiple sclerosis	4.56e-05	0.000737	CcSEcCtD
Daunorubicin—Arrhythmia—Prednisone—multiple sclerosis	4.54e-05	0.000734	CcSEcCtD
Daunorubicin—Infection—Triamcinolone—multiple sclerosis	4.54e-05	0.000734	CcSEcCtD
Daunorubicin—Infection—Methylprednisolone—multiple sclerosis	4.53e-05	0.000732	CcSEcCtD
Daunorubicin—Shock—Triamcinolone—multiple sclerosis	4.5e-05	0.000727	CcSEcCtD
Daunorubicin—Insomnia—Prednisolone—multiple sclerosis	4.5e-05	0.000727	CcSEcCtD
Daunorubicin—Alopecia—Prednisone—multiple sclerosis	4.49e-05	0.000726	CcSEcCtD
Daunorubicin—ABCB1—nervous system—multiple sclerosis	4.49e-05	0.00385	CbGeAlD
Daunorubicin—Shock—Methylprednisolone—multiple sclerosis	4.49e-05	0.000725	CcSEcCtD
Daunorubicin—Loss of consciousness—Dexamethasone—multiple sclerosis	4.47e-05	0.000722	CcSEcCtD
Daunorubicin—Loss of consciousness—Betamethasone—multiple sclerosis	4.47e-05	0.000722	CcSEcCtD
Daunorubicin—Hypersensitivity—Mitoxantrone—multiple sclerosis	4.47e-05	0.000721	CcSEcCtD
Daunorubicin—Tachycardia—Triamcinolone—multiple sclerosis	4.46e-05	0.000721	CcSEcCtD
Daunorubicin—Nausea—Azathioprine—multiple sclerosis	4.45e-05	0.000719	CcSEcCtD
Daunorubicin—Tachycardia—Methylprednisolone—multiple sclerosis	4.45e-05	0.000719	CcSEcCtD
Daunorubicin—Erythema—Prednisone—multiple sclerosis	4.43e-05	0.000715	CcSEcCtD
Daunorubicin—Hyperhidrosis—Triamcinolone—multiple sclerosis	4.42e-05	0.000714	CcSEcCtD
Daunorubicin—Hyperhidrosis—Methylprednisolone—multiple sclerosis	4.41e-05	0.000713	CcSEcCtD
Daunorubicin—Convulsion—Betamethasone—multiple sclerosis	4.4e-05	0.000712	CcSEcCtD
Daunorubicin—Convulsion—Dexamethasone—multiple sclerosis	4.4e-05	0.000712	CcSEcCtD
Daunorubicin—Hypertension—Betamethasone—multiple sclerosis	4.39e-05	0.000709	CcSEcCtD
Daunorubicin—Hypertension—Dexamethasone—multiple sclerosis	4.39e-05	0.000709	CcSEcCtD
Daunorubicin—Asthenia—Mitoxantrone—multiple sclerosis	4.35e-05	0.000703	CcSEcCtD
Daunorubicin—Myalgia—Dexamethasone—multiple sclerosis	4.33e-05	0.000699	CcSEcCtD
Daunorubicin—Myalgia—Betamethasone—multiple sclerosis	4.33e-05	0.000699	CcSEcCtD
Daunorubicin—ABCB1—central nervous system—multiple sclerosis	4.32e-05	0.00371	CbGeAlD
Daunorubicin—Anxiety—Dexamethasone—multiple sclerosis	4.31e-05	0.000697	CcSEcCtD
Daunorubicin—Anxiety—Betamethasone—multiple sclerosis	4.31e-05	0.000697	CcSEcCtD
Daunorubicin—Discomfort—Dexamethasone—multiple sclerosis	4.28e-05	0.000691	CcSEcCtD
Daunorubicin—Discomfort—Betamethasone—multiple sclerosis	4.28e-05	0.000691	CcSEcCtD
Daunorubicin—Pain—Prednisolone—multiple sclerosis	4.25e-05	0.000687	CcSEcCtD
Daunorubicin—ABCB1—cerebellum—multiple sclerosis	4.23e-05	0.00363	CbGeAlD
Daunorubicin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	4.17e-05	0.000673	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	4.16e-05	0.000672	CcSEcCtD
Daunorubicin—Oedema—Dexamethasone—multiple sclerosis	4.15e-05	0.00067	CcSEcCtD
Daunorubicin—Oedema—Betamethasone—multiple sclerosis	4.15e-05	0.00067	CcSEcCtD
Daunorubicin—Anaphylactic shock—Dexamethasone—multiple sclerosis	4.15e-05	0.00067	CcSEcCtD
Daunorubicin—Anaphylactic shock—Betamethasone—multiple sclerosis	4.15e-05	0.00067	CcSEcCtD
Daunorubicin—Diarrhoea—Mitoxantrone—multiple sclerosis	4.15e-05	0.00067	CcSEcCtD
Daunorubicin—Insomnia—Triamcinolone—multiple sclerosis	4.14e-05	0.000668	CcSEcCtD
Daunorubicin—Insomnia—Methylprednisolone—multiple sclerosis	4.13e-05	0.000667	CcSEcCtD
Daunorubicin—Infection—Betamethasone—multiple sclerosis	4.12e-05	0.000666	CcSEcCtD
Daunorubicin—Infection—Dexamethasone—multiple sclerosis	4.12e-05	0.000666	CcSEcCtD
Daunorubicin—Ill-defined disorder—Prednisone—multiple sclerosis	4.11e-05	0.000664	CcSEcCtD
Daunorubicin—Feeling abnormal—Prednisolone—multiple sclerosis	4.1e-05	0.000662	CcSEcCtD
Daunorubicin—Visual impairment—Methotrexate—multiple sclerosis	4.1e-05	0.000662	CcSEcCtD
Daunorubicin—Anaemia—Prednisone—multiple sclerosis	4.09e-05	0.000661	CcSEcCtD
Daunorubicin—Shock—Dexamethasone—multiple sclerosis	4.08e-05	0.000659	CcSEcCtD
Daunorubicin—Shock—Betamethasone—multiple sclerosis	4.08e-05	0.000659	CcSEcCtD
Daunorubicin—Dyspnoea—Triamcinolone—multiple sclerosis	4.08e-05	0.000659	CcSEcCtD
Daunorubicin—Agitation—Prednisone—multiple sclerosis	4.07e-05	0.000657	CcSEcCtD
Daunorubicin—Thrombocytopenia—Dexamethasone—multiple sclerosis	4.06e-05	0.000656	CcSEcCtD
Daunorubicin—Thrombocytopenia—Betamethasone—multiple sclerosis	4.06e-05	0.000656	CcSEcCtD
Daunorubicin—Tachycardia—Dexamethasone—multiple sclerosis	4.05e-05	0.000654	CcSEcCtD
Daunorubicin—Tachycardia—Betamethasone—multiple sclerosis	4.05e-05	0.000654	CcSEcCtD
Daunorubicin—Hyperhidrosis—Dexamethasone—multiple sclerosis	4.01e-05	0.000648	CcSEcCtD
Daunorubicin—Hyperhidrosis—Betamethasone—multiple sclerosis	4.01e-05	0.000648	CcSEcCtD
Daunorubicin—Malaise—Prednisone—multiple sclerosis	3.99e-05	0.000645	CcSEcCtD
Daunorubicin—Syncope—Prednisone—multiple sclerosis	3.97e-05	0.000641	CcSEcCtD
Daunorubicin—Tinnitus—Methotrexate—multiple sclerosis	3.96e-05	0.00064	CcSEcCtD
Daunorubicin—Anorexia—Betamethasone—multiple sclerosis	3.95e-05	0.000639	CcSEcCtD
Daunorubicin—Anorexia—Dexamethasone—multiple sclerosis	3.95e-05	0.000639	CcSEcCtD
Daunorubicin—Urticaria—Prednisolone—multiple sclerosis	3.95e-05	0.000638	CcSEcCtD
Daunorubicin—Cardiac disorder—Methotrexate—multiple sclerosis	3.94e-05	0.000637	CcSEcCtD
Daunorubicin—Fatigue—Triamcinolone—multiple sclerosis	3.94e-05	0.000637	CcSEcCtD
Daunorubicin—Fatigue—Methylprednisolone—multiple sclerosis	3.93e-05	0.000635	CcSEcCtD
Daunorubicin—Pain—Triamcinolone—multiple sclerosis	3.91e-05	0.000632	CcSEcCtD
Daunorubicin—Loss of consciousness—Prednisone—multiple sclerosis	3.89e-05	0.000629	CcSEcCtD
Daunorubicin—Vomiting—Mitoxantrone—multiple sclerosis	3.85e-05	0.000623	CcSEcCtD
Daunorubicin—Convulsion—Prednisone—multiple sclerosis	3.84e-05	0.00062	CcSEcCtD
Daunorubicin—Hypertension—Prednisone—multiple sclerosis	3.82e-05	0.000618	CcSEcCtD
Daunorubicin—Rash—Mitoxantrone—multiple sclerosis	3.82e-05	0.000617	CcSEcCtD
Daunorubicin—Dermatitis—Mitoxantrone—multiple sclerosis	3.82e-05	0.000617	CcSEcCtD
Daunorubicin—Chills—Methotrexate—multiple sclerosis	3.81e-05	0.000616	CcSEcCtD
Daunorubicin—Headache—Mitoxantrone—multiple sclerosis	3.8e-05	0.000613	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	3.78e-05	0.000611	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	3.78e-05	0.000611	CcSEcCtD
Daunorubicin—Arthralgia—Prednisone—multiple sclerosis	3.77e-05	0.000609	CcSEcCtD
Daunorubicin—Myalgia—Prednisone—multiple sclerosis	3.77e-05	0.000609	CcSEcCtD
Daunorubicin—Feeling abnormal—Triamcinolone—multiple sclerosis	3.77e-05	0.000609	CcSEcCtD
Daunorubicin—Feeling abnormal—Methylprednisolone—multiple sclerosis	3.76e-05	0.000607	CcSEcCtD
Daunorubicin—Anxiety—Prednisone—multiple sclerosis	3.76e-05	0.000607	CcSEcCtD
Daunorubicin—Alopecia—Methotrexate—multiple sclerosis	3.76e-05	0.000607	CcSEcCtD
Daunorubicin—Insomnia—Betamethasone—multiple sclerosis	3.75e-05	0.000606	CcSEcCtD
Daunorubicin—Insomnia—Dexamethasone—multiple sclerosis	3.75e-05	0.000606	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	3.73e-05	0.000603	CcSEcCtD
Daunorubicin—Discomfort—Prednisone—multiple sclerosis	3.72e-05	0.000602	CcSEcCtD
Daunorubicin—Erythema—Methotrexate—multiple sclerosis	3.7e-05	0.000598	CcSEcCtD
Daunorubicin—Hypersensitivity—Prednisolone—multiple sclerosis	3.66e-05	0.000592	CcSEcCtD
Daunorubicin—Urticaria—Triamcinolone—multiple sclerosis	3.63e-05	0.000587	CcSEcCtD
Daunorubicin—Urticaria—Methylprednisolone—multiple sclerosis	3.62e-05	0.000586	CcSEcCtD
Daunorubicin—Dysgeusia—Methotrexate—multiple sclerosis	3.62e-05	0.000585	CcSEcCtD
Daunorubicin—Body temperature increased—Triamcinolone—multiple sclerosis	3.61e-05	0.000584	CcSEcCtD
Daunorubicin—Anaphylactic shock—Prednisone—multiple sclerosis	3.61e-05	0.000584	CcSEcCtD
Daunorubicin—Oedema—Prednisone—multiple sclerosis	3.61e-05	0.000584	CcSEcCtD
Daunorubicin—Abdominal pain—Methylprednisolone—multiple sclerosis	3.61e-05	0.000583	CcSEcCtD
Daunorubicin—Decreased appetite—Dexamethasone—multiple sclerosis	3.61e-05	0.000583	CcSEcCtD
Daunorubicin—Decreased appetite—Betamethasone—multiple sclerosis	3.61e-05	0.000583	CcSEcCtD
Daunorubicin—Nausea—Mitoxantrone—multiple sclerosis	3.6e-05	0.000582	CcSEcCtD
Daunorubicin—Infection—Prednisone—multiple sclerosis	3.59e-05	0.00058	CcSEcCtD
Daunorubicin—Back pain—Methotrexate—multiple sclerosis	3.58e-05	0.000578	CcSEcCtD
Daunorubicin—Fatigue—Betamethasone—multiple sclerosis	3.58e-05	0.000578	CcSEcCtD
Daunorubicin—Fatigue—Dexamethasone—multiple sclerosis	3.58e-05	0.000578	CcSEcCtD
Daunorubicin—Shock—Prednisone—multiple sclerosis	3.55e-05	0.000574	CcSEcCtD
Daunorubicin—Pain—Betamethasone—multiple sclerosis	3.55e-05	0.000573	CcSEcCtD
Daunorubicin—Pain—Dexamethasone—multiple sclerosis	3.55e-05	0.000573	CcSEcCtD
Daunorubicin—Tachycardia—Prednisone—multiple sclerosis	3.53e-05	0.00057	CcSEcCtD
Daunorubicin—Hyperhidrosis—Prednisone—multiple sclerosis	3.49e-05	0.000564	CcSEcCtD
Daunorubicin—Anorexia—Prednisone—multiple sclerosis	3.44e-05	0.000556	CcSEcCtD
Daunorubicin—ABCB1—brain—multiple sclerosis	3.43e-05	0.00295	CbGeAlD
Daunorubicin—Ill-defined disorder—Methotrexate—multiple sclerosis	3.43e-05	0.000555	CcSEcCtD
Daunorubicin—Anaemia—Methotrexate—multiple sclerosis	3.42e-05	0.000552	CcSEcCtD
Daunorubicin—Feeling abnormal—Dexamethasone—multiple sclerosis	3.42e-05	0.000552	CcSEcCtD
Daunorubicin—Feeling abnormal—Betamethasone—multiple sclerosis	3.42e-05	0.000552	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	3.39e-05	0.000548	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Betamethasone—multiple sclerosis	3.39e-05	0.000548	CcSEcCtD
Daunorubicin—Hypersensitivity—Triamcinolone—multiple sclerosis	3.37e-05	0.000544	CcSEcCtD
Daunorubicin—Hypersensitivity—Methylprednisolone—multiple sclerosis	3.36e-05	0.000543	CcSEcCtD
Daunorubicin—Malaise—Methotrexate—multiple sclerosis	3.34e-05	0.000539	CcSEcCtD
Daunorubicin—Leukopenia—Methotrexate—multiple sclerosis	3.31e-05	0.000535	CcSEcCtD
Daunorubicin—Urticaria—Dexamethasone—multiple sclerosis	3.3e-05	0.000532	CcSEcCtD
Daunorubicin—Urticaria—Betamethasone—multiple sclerosis	3.3e-05	0.000532	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	3.29e-05	0.000532	CcSEcCtD
Daunorubicin—Dizziness—Prednisolone—multiple sclerosis	3.29e-05	0.000531	CcSEcCtD
Daunorubicin—Asthenia—Triamcinolone—multiple sclerosis	3.28e-05	0.00053	CcSEcCtD
Daunorubicin—Abdominal pain—Betamethasone—multiple sclerosis	3.28e-05	0.00053	CcSEcCtD
Daunorubicin—Body temperature increased—Betamethasone—multiple sclerosis	3.28e-05	0.00053	CcSEcCtD
Daunorubicin—Body temperature increased—Dexamethasone—multiple sclerosis	3.28e-05	0.00053	CcSEcCtD
Daunorubicin—Abdominal pain—Dexamethasone—multiple sclerosis	3.28e-05	0.00053	CcSEcCtD
Daunorubicin—Asthenia—Methylprednisolone—multiple sclerosis	3.27e-05	0.000529	CcSEcCtD
Daunorubicin—Insomnia—Prednisone—multiple sclerosis	3.27e-05	0.000528	CcSEcCtD
Daunorubicin—Pruritus—Triamcinolone—multiple sclerosis	3.23e-05	0.000523	CcSEcCtD
Daunorubicin—Cough—Methotrexate—multiple sclerosis	3.23e-05	0.000522	CcSEcCtD
Daunorubicin—Pruritus—Methylprednisolone—multiple sclerosis	3.23e-05	0.000521	CcSEcCtD
Daunorubicin—Convulsion—Methotrexate—multiple sclerosis	3.21e-05	0.000518	CcSEcCtD
Daunorubicin—Arthralgia—Methotrexate—multiple sclerosis	3.15e-05	0.000509	CcSEcCtD
Daunorubicin—Chest pain—Methotrexate—multiple sclerosis	3.15e-05	0.000509	CcSEcCtD
Daunorubicin—Myalgia—Methotrexate—multiple sclerosis	3.15e-05	0.000509	CcSEcCtD
Daunorubicin—Decreased appetite—Prednisone—multiple sclerosis	3.14e-05	0.000507	CcSEcCtD
Daunorubicin—Rash—Prednisolone—multiple sclerosis	3.14e-05	0.000506	CcSEcCtD
Daunorubicin—Dermatitis—Prednisolone—multiple sclerosis	3.13e-05	0.000506	CcSEcCtD
Daunorubicin—Diarrhoea—Methylprednisolone—multiple sclerosis	3.12e-05	0.000504	CcSEcCtD
Daunorubicin—Fatigue—Prednisone—multiple sclerosis	3.12e-05	0.000503	CcSEcCtD
Daunorubicin—Headache—Prednisolone—multiple sclerosis	3.11e-05	0.000503	CcSEcCtD
Daunorubicin—Discomfort—Methotrexate—multiple sclerosis	3.11e-05	0.000503	CcSEcCtD
Daunorubicin—Constipation—Prednisone—multiple sclerosis	3.09e-05	0.000499	CcSEcCtD
Daunorubicin—Confusional state—Methotrexate—multiple sclerosis	3.04e-05	0.000492	CcSEcCtD
Daunorubicin—Dizziness—Triamcinolone—multiple sclerosis	3.02e-05	0.000489	CcSEcCtD
Daunorubicin—Anaphylactic shock—Methotrexate—multiple sclerosis	3.02e-05	0.000488	CcSEcCtD
Daunorubicin—Dizziness—Methylprednisolone—multiple sclerosis	3.02e-05	0.000487	CcSEcCtD
Daunorubicin—Infection—Methotrexate—multiple sclerosis	3e-05	0.000485	CcSEcCtD
Daunorubicin—Feeling abnormal—Prednisone—multiple sclerosis	2.98e-05	0.000481	CcSEcCtD
Daunorubicin—Asthenia—Betamethasone—multiple sclerosis	2.98e-05	0.000481	CcSEcCtD
Daunorubicin—Asthenia—Dexamethasone—multiple sclerosis	2.98e-05	0.000481	CcSEcCtD
Daunorubicin—Thrombocytopenia—Methotrexate—multiple sclerosis	2.96e-05	0.000478	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Prednisone—multiple sclerosis	2.95e-05	0.000477	CcSEcCtD
Daunorubicin—Nausea—Prednisolone—multiple sclerosis	2.95e-05	0.000477	CcSEcCtD
Daunorubicin—Pruritus—Betamethasone—multiple sclerosis	2.94e-05	0.000474	CcSEcCtD
Daunorubicin—Pruritus—Dexamethasone—multiple sclerosis	2.94e-05	0.000474	CcSEcCtD
Daunorubicin—Hyperhidrosis—Methotrexate—multiple sclerosis	2.92e-05	0.000472	CcSEcCtD
Daunorubicin—Vomiting—Triamcinolone—multiple sclerosis	2.91e-05	0.00047	CcSEcCtD
Daunorubicin—Vomiting—Methylprednisolone—multiple sclerosis	2.9e-05	0.000469	CcSEcCtD
Daunorubicin—Rash—Triamcinolone—multiple sclerosis	2.88e-05	0.000466	CcSEcCtD
Daunorubicin—Dermatitis—Triamcinolone—multiple sclerosis	2.88e-05	0.000465	CcSEcCtD
Daunorubicin—Anorexia—Methotrexate—multiple sclerosis	2.88e-05	0.000465	CcSEcCtD
Daunorubicin—Rash—Methylprednisolone—multiple sclerosis	2.88e-05	0.000465	CcSEcCtD
Daunorubicin—Dermatitis—Methylprednisolone—multiple sclerosis	2.87e-05	0.000464	CcSEcCtD
Daunorubicin—Urticaria—Prednisone—multiple sclerosis	2.87e-05	0.000464	CcSEcCtD
Daunorubicin—Headache—Triamcinolone—multiple sclerosis	2.86e-05	0.000463	CcSEcCtD
Daunorubicin—Headache—Methylprednisolone—multiple sclerosis	2.86e-05	0.000462	CcSEcCtD
Daunorubicin—Body temperature increased—Prednisone—multiple sclerosis	2.86e-05	0.000461	CcSEcCtD
Daunorubicin—Abdominal pain—Prednisone—multiple sclerosis	2.86e-05	0.000461	CcSEcCtD
Daunorubicin—Diarrhoea—Betamethasone—multiple sclerosis	2.84e-05	0.000459	CcSEcCtD
Daunorubicin—Diarrhoea—Dexamethasone—multiple sclerosis	2.84e-05	0.000459	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	2.75e-05	0.000444	CcSEcCtD
Daunorubicin—Dizziness—Betamethasone—multiple sclerosis	2.74e-05	0.000443	CcSEcCtD
Daunorubicin—Dizziness—Dexamethasone—multiple sclerosis	2.74e-05	0.000443	CcSEcCtD
Daunorubicin—Insomnia—Methotrexate—multiple sclerosis	2.73e-05	0.000441	CcSEcCtD
Daunorubicin—Nausea—Triamcinolone—multiple sclerosis	2.72e-05	0.000439	CcSEcCtD
Daunorubicin—Nausea—Methylprednisolone—multiple sclerosis	2.71e-05	0.000438	CcSEcCtD
Daunorubicin—Dyspnoea—Methotrexate—multiple sclerosis	2.69e-05	0.000435	CcSEcCtD
Daunorubicin—Somnolence—Methotrexate—multiple sclerosis	2.68e-05	0.000434	CcSEcCtD
Daunorubicin—Hypersensitivity—Prednisone—multiple sclerosis	2.66e-05	0.00043	CcSEcCtD
Daunorubicin—Vomiting—Dexamethasone—multiple sclerosis	2.64e-05	0.000426	CcSEcCtD
Daunorubicin—Vomiting—Betamethasone—multiple sclerosis	2.64e-05	0.000426	CcSEcCtD
Daunorubicin—Decreased appetite—Methotrexate—multiple sclerosis	2.62e-05	0.000424	CcSEcCtD
Daunorubicin—Rash—Dexamethasone—multiple sclerosis	2.62e-05	0.000423	CcSEcCtD
Daunorubicin—Rash—Betamethasone—multiple sclerosis	2.62e-05	0.000423	CcSEcCtD
Daunorubicin—Dermatitis—Betamethasone—multiple sclerosis	2.61e-05	0.000422	CcSEcCtD
Daunorubicin—Dermatitis—Dexamethasone—multiple sclerosis	2.61e-05	0.000422	CcSEcCtD
Daunorubicin—Fatigue—Methotrexate—multiple sclerosis	2.6e-05	0.000421	CcSEcCtD
Daunorubicin—Headache—Betamethasone—multiple sclerosis	2.6e-05	0.00042	CcSEcCtD
Daunorubicin—Headache—Dexamethasone—multiple sclerosis	2.6e-05	0.00042	CcSEcCtD
Daunorubicin—Asthenia—Prednisone—multiple sclerosis	2.59e-05	0.000419	CcSEcCtD
Daunorubicin—Pain—Methotrexate—multiple sclerosis	2.58e-05	0.000417	CcSEcCtD
Daunorubicin—Pruritus—Prednisone—multiple sclerosis	2.56e-05	0.000413	CcSEcCtD
Daunorubicin—Feeling abnormal—Methotrexate—multiple sclerosis	2.49e-05	0.000402	CcSEcCtD
Daunorubicin—Diarrhoea—Prednisone—multiple sclerosis	2.47e-05	0.000399	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Methotrexate—multiple sclerosis	2.47e-05	0.000399	CcSEcCtD
Daunorubicin—Nausea—Dexamethasone—multiple sclerosis	2.46e-05	0.000398	CcSEcCtD
Daunorubicin—Nausea—Betamethasone—multiple sclerosis	2.46e-05	0.000398	CcSEcCtD
Daunorubicin—NR5A1—Developmental Biology—TYK2—multiple sclerosis	2.44e-05	0.00107	CbGpPWpGaD
Daunorubicin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	2.4e-05	0.00105	CbGpPWpGaD
Daunorubicin—Urticaria—Methotrexate—multiple sclerosis	2.4e-05	0.000388	CcSEcCtD
Daunorubicin—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.39e-05	0.00105	CbGpPWpGaD
Daunorubicin—Dizziness—Prednisone—multiple sclerosis	2.39e-05	0.000386	CcSEcCtD
Daunorubicin—Body temperature increased—Methotrexate—multiple sclerosis	2.39e-05	0.000386	CcSEcCtD
Daunorubicin—Abdominal pain—Methotrexate—multiple sclerosis	2.39e-05	0.000386	CcSEcCtD
Daunorubicin—XDH—Metabolism—CYP24A1—multiple sclerosis	2.37e-05	0.00104	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—CYP27B1—multiple sclerosis	2.37e-05	0.00104	CbGpPWpGaD
Daunorubicin—XDH—Selenium Micronutrient Network—IL6—multiple sclerosis	2.32e-05	0.00102	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.31e-05	0.00101	CbGpPWpGaD
Daunorubicin—Vomiting—Prednisone—multiple sclerosis	2.3e-05	0.000371	CcSEcCtD
Daunorubicin—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	2.3e-05	0.00101	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.29e-05	0.001	CbGpPWpGaD
Daunorubicin—Rash—Prednisone—multiple sclerosis	2.28e-05	0.000368	CcSEcCtD
Daunorubicin—Dermatitis—Prednisone—multiple sclerosis	2.28e-05	0.000368	CcSEcCtD
Daunorubicin—Headache—Prednisone—multiple sclerosis	2.26e-05	0.000366	CcSEcCtD
Daunorubicin—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	2.25e-05	0.000987	CbGpPWpGaD
Daunorubicin—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	2.25e-05	0.000987	CbGpPWpGaD
Daunorubicin—Hypersensitivity—Methotrexate—multiple sclerosis	2.22e-05	0.000359	CcSEcCtD
Daunorubicin—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	2.22e-05	0.000974	CbGpPWpGaD
Daunorubicin—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	2.22e-05	0.000974	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—CD86—multiple sclerosis	2.21e-05	0.000969	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	2.19e-05	0.000962	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	2.19e-05	0.000958	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—GPC5—multiple sclerosis	2.17e-05	0.000951	CbGpPWpGaD
Daunorubicin—ABCC6—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.17e-05	0.000951	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	2.17e-05	0.00095	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—IL10—multiple sclerosis	2.17e-05	0.00095	CbGpPWpGaD
Daunorubicin—Asthenia—Methotrexate—multiple sclerosis	2.17e-05	0.00035	CcSEcCtD
Daunorubicin—Nausea—Prednisone—multiple sclerosis	2.15e-05	0.000347	CcSEcCtD
Daunorubicin—Pruritus—Methotrexate—multiple sclerosis	2.14e-05	0.000345	CcSEcCtD
Daunorubicin—ABCB1—Allograft Rejection—IL4—multiple sclerosis	2.11e-05	0.000924	CbGpPWpGaD
Daunorubicin—YWHAG—Apoptosis—TNF—multiple sclerosis	2.09e-05	0.000916	CbGpPWpGaD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—TNF—multiple sclerosis	2.08e-05	0.000911	CbGpPWpGaD
Daunorubicin—Diarrhoea—Methotrexate—multiple sclerosis	2.07e-05	0.000334	CcSEcCtD
Daunorubicin—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	2.06e-05	0.000904	CbGpPWpGaD
Daunorubicin—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.05e-05	0.000899	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—VDR—multiple sclerosis	2.04e-05	0.000896	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.01e-05	0.000882	CbGpPWpGaD
Daunorubicin—Dizziness—Methotrexate—multiple sclerosis	2e-05	0.000323	CcSEcCtD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.99e-05	0.000873	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—BCHE—multiple sclerosis	1.98e-05	0.000867	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—FAS—multiple sclerosis	1.94e-05	0.000852	CbGpPWpGaD
Daunorubicin—CYP1A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.94e-05	0.00085	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	1.93e-05	0.000847	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—MMP9—multiple sclerosis	1.92e-05	0.000843	CbGpPWpGaD
Daunorubicin—Vomiting—Methotrexate—multiple sclerosis	1.92e-05	0.00031	CcSEcCtD
Daunorubicin—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	1.91e-05	0.000838	CbGpPWpGaD
Daunorubicin—Rash—Methotrexate—multiple sclerosis	1.9e-05	0.000308	CcSEcCtD
Daunorubicin—Dermatitis—Methotrexate—multiple sclerosis	1.9e-05	0.000307	CcSEcCtD
Daunorubicin—ABCC10—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.9e-05	0.000831	CbGpPWpGaD
Daunorubicin—Headache—Methotrexate—multiple sclerosis	1.89e-05	0.000306	CcSEcCtD
Daunorubicin—ABCC1—Metabolism—SRM—multiple sclerosis	1.86e-05	0.000818	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.83e-05	0.000802	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.81e-05	0.000793	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—SRM—multiple sclerosis	1.8e-05	0.000791	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—RRM1—multiple sclerosis	1.8e-05	0.000788	CbGpPWpGaD
Daunorubicin—Nausea—Methotrexate—multiple sclerosis	1.79e-05	0.00029	CcSEcCtD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.76e-05	0.00077	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.76e-05	0.00077	CbGpPWpGaD
Daunorubicin—TOP2A—Mitotic G1-G1/S phases—MYC—multiple sclerosis	1.75e-05	0.000768	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—CYP27B1—multiple sclerosis	1.75e-05	0.000767	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—CYP24A1—multiple sclerosis	1.75e-05	0.000767	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	1.75e-05	0.000765	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.71e-05	0.000749	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—STAT3—multiple sclerosis	1.71e-05	0.000749	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	1.71e-05	0.000749	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	1.7e-05	0.000747	CbGpPWpGaD
Daunorubicin—NR5A1—Generic Transcription Pathway—MYC—multiple sclerosis	1.69e-05	0.00074	CbGpPWpGaD
Daunorubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—IL6—multiple sclerosis	1.69e-05	0.000739	CbGpPWpGaD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—IL6—multiple sclerosis	1.68e-05	0.000735	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	1.67e-05	0.000733	CbGpPWpGaD
Daunorubicin—CYP1B1—Biological oxidations—POMC—multiple sclerosis	1.67e-05	0.000733	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—SRM—multiple sclerosis	1.64e-05	0.000719	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—SRM—multiple sclerosis	1.62e-05	0.000712	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.62e-05	0.000709	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—CD80—multiple sclerosis	1.61e-05	0.000707	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—GPC5—multiple sclerosis	1.6e-05	0.000701	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.6e-05	0.000701	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	1.59e-05	0.000698	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	1.59e-05	0.000698	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.59e-05	0.000697	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—TGFB1—multiple sclerosis	1.58e-05	0.000695	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.57e-05	0.00069	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	1.57e-05	0.000688	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—MAPK1—multiple sclerosis	1.55e-05	0.000681	CbGpPWpGaD
Daunorubicin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.52e-05	0.000668	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—TNF—multiple sclerosis	1.48e-05	0.000649	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.44e-05	0.000629	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—GPC5—multiple sclerosis	1.43e-05	0.000629	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.41e-05	0.000616	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	1.4e-05	0.000613	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	1.4e-05	0.000612	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	1.39e-05	0.000611	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.39e-05	0.00061	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.33e-05	0.000582	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—RRM1—multiple sclerosis	1.33e-05	0.000581	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.32e-05	0.000581	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CYP27B1—multiple sclerosis	1.31e-05	0.000576	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CYP24A1—multiple sclerosis	1.31e-05	0.000576	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.3e-05	0.000569	CbGpPWpGaD
Daunorubicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	1.3e-05	0.000569	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.28e-05	0.000563	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	1.27e-05	0.000559	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CYP24A1—multiple sclerosis	1.27e-05	0.000557	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CYP27B1—multiple sclerosis	1.27e-05	0.000557	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.24e-05	0.000545	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.24e-05	0.000542	CbGpPWpGaD
Daunorubicin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.24e-05	0.000542	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GPC5—multiple sclerosis	1.2e-05	0.000527	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—IL6—multiple sclerosis	1.19e-05	0.000523	CbGpPWpGaD
Daunorubicin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.18e-05	0.000516	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—SRM—multiple sclerosis	1.18e-05	0.000515	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GPC5—multiple sclerosis	1.16e-05	0.00051	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CYP27B1—multiple sclerosis	1.16e-05	0.000507	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CYP24A1—multiple sclerosis	1.16e-05	0.000507	CbGpPWpGaD
Daunorubicin—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	1.15e-05	0.000504	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CYP27B1—multiple sclerosis	1.14e-05	0.000502	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CYP24A1—multiple sclerosis	1.14e-05	0.000502	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	1.14e-05	0.000498	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—IL2—multiple sclerosis	1.13e-05	0.000497	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	1.12e-05	0.000491	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.12e-05	0.000491	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.12e-05	0.000491	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—SRM—multiple sclerosis	1.11e-05	0.000487	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	1.09e-05	0.000478	CbGpPWpGaD
Daunorubicin—CYP3A5—Biological oxidations—POMC—multiple sclerosis	1.09e-05	0.000478	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.09e-05	0.000477	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	1.09e-05	0.000477	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	1.07e-05	0.000467	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GPC5—multiple sclerosis	1.06e-05	0.000464	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GPC5—multiple sclerosis	1.05e-05	0.000459	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—BCHE—multiple sclerosis	1.03e-05	0.000453	CbGpPWpGaD
Daunorubicin—CYP1A1—Biological oxidations—POMC—multiple sclerosis	1.03e-05	0.000451	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.03e-05	0.000451	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	1.02e-05	0.000445	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	1.02e-05	0.000445	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—RRM1—multiple sclerosis	9.96e-06	0.000437	CbGpPWpGaD
Daunorubicin—SLC22A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	9.86e-06	0.000432	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—RRM1—multiple sclerosis	9.63e-06	0.000422	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	9.59e-06	0.00042	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—IL6—multiple sclerosis	9.58e-06	0.00042	CbGpPWpGaD
Daunorubicin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.54e-06	0.000418	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—RPL5—multiple sclerosis	9.33e-06	0.000409	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—MYC—multiple sclerosis	9.19e-06	0.000403	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	8.99e-06	0.000394	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SLC11A1—multiple sclerosis	8.94e-06	0.000392	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SRM—multiple sclerosis	8.87e-06	0.000389	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	8.83e-06	0.000387	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.83e-06	0.000387	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—RRM1—multiple sclerosis	8.76e-06	0.000384	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—RRM1—multiple sclerosis	8.67e-06	0.00038	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.6e-06	0.000377	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	8.28e-06	0.000363	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	8.28e-06	0.000363	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—TNF—multiple sclerosis	8.25e-06	0.000362	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—MYC—multiple sclerosis	8.21e-06	0.00036	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—MYC—multiple sclerosis	8.12e-06	0.000356	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.05e-06	0.000353	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—MAPK1—multiple sclerosis	8.04e-06	0.000352	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CYP27B1—multiple sclerosis	7.83e-06	0.000343	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CYP24A1—multiple sclerosis	7.83e-06	0.000343	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.72e-06	0.000339	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.65e-06	0.000335	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—BCHE—multiple sclerosis	7.61e-06	0.000334	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.6e-06	0.000333	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GPC5—multiple sclerosis	7.58e-06	0.000332	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	7.54e-06	0.000331	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.47e-06	0.000328	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GPC5—multiple sclerosis	7.16e-06	0.000314	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CD28—multiple sclerosis	7.14e-06	0.000313	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SRM—multiple sclerosis	7.08e-06	0.00031	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.64e-06	0.000291	CbGpPWpGaD
Daunorubicin—CYP1A2—Biological oxidations—POMC—multiple sclerosis	6.56e-06	0.000288	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—MYC—multiple sclerosis	6.43e-06	0.000282	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.42e-06	0.000281	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	6.29e-06	0.000276	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—RRM1—multiple sclerosis	6.28e-06	0.000275	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP27B1—multiple sclerosis	6.25e-06	0.000274	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP24A1—multiple sclerosis	6.25e-06	0.000274	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—APOE—multiple sclerosis	6.21e-06	0.000272	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.05e-06	0.000265	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—RRM1—multiple sclerosis	5.93e-06	0.00026	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.85e-06	0.000257	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.82e-06	0.000255	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—MAPK1—multiple sclerosis	5.78e-06	0.000253	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.75e-06	0.000252	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—MYC—multiple sclerosis	5.75e-06	0.000252	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—BCHE—multiple sclerosis	5.72e-06	0.000251	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GPC5—multiple sclerosis	5.72e-06	0.000251	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—MAPK1—multiple sclerosis	5.62e-06	0.000246	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—BCHE—multiple sclerosis	5.53e-06	0.000243	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SRM—multiple sclerosis	5.47e-06	0.00024	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—POMC—multiple sclerosis	5.34e-06	0.000234	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CD86—multiple sclerosis	5.09e-06	0.000223	CbGpPWpGaD
Daunorubicin—CYP3A4—Biological oxidations—POMC—multiple sclerosis	5.07e-06	0.000222	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.06e-06	0.000222	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—BCHE—multiple sclerosis	5.03e-06	0.000221	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.01e-06	0.00022	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	4.99e-06	0.000219	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	4.99e-06	0.000219	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—BCHE—multiple sclerosis	4.98e-06	0.000218	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.88e-06	0.000214	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—ALB—multiple sclerosis	4.86e-06	0.000213	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—RRM1—multiple sclerosis	4.74e-06	0.000208	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.6e-06	0.000202	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—APOE—multiple sclerosis	4.58e-06	0.000201	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GPC5—multiple sclerosis	4.56e-06	0.0002	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CCR5—multiple sclerosis	4.52e-06	0.000198	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HLA-A—multiple sclerosis	4.4e-06	0.000193	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	4.37e-06	0.000192	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	4.36e-06	0.000191	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	4.28e-06	0.000187	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—APOE—multiple sclerosis	4.11e-06	0.00018	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	4.07e-06	0.000178	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.95e-06	0.000173	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—POMC—multiple sclerosis	3.93e-06	0.000172	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	3.85e-06	0.000169	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	3.85e-06	0.000169	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—RRM1—multiple sclerosis	3.78e-06	0.000166	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CD80—multiple sclerosis	3.71e-06	0.000163	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—BCHE—multiple sclerosis	3.61e-06	0.000158	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.6e-06	0.000158	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—ALB—multiple sclerosis	3.59e-06	0.000157	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GPC5—multiple sclerosis	3.52e-06	0.000154	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—APOE—multiple sclerosis	3.44e-06	0.000151	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—BCHE—multiple sclerosis	3.41e-06	0.000149	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—APOE—multiple sclerosis	3.33e-06	0.000146	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TYK2—multiple sclerosis	3.14e-06	0.000137	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—APOE—multiple sclerosis	3.03e-06	0.000133	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—APOE—multiple sclerosis	3e-06	0.000131	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—POMC—multiple sclerosis	2.96e-06	0.00013	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.93e-06	0.000129	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.92e-06	0.000128	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—POMC—multiple sclerosis	2.86e-06	0.000125	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CD4—multiple sclerosis	2.84e-06	0.000124	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.74e-06	0.00012	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—BCHE—multiple sclerosis	2.72e-06	0.000119	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—ALB—multiple sclerosis	2.69e-06	0.000118	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—ALB—multiple sclerosis	2.61e-06	0.000114	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—POMC—multiple sclerosis	2.6e-06	0.000114	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—POMC—multiple sclerosis	2.57e-06	0.000113	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.52e-06	0.00011	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ALB—multiple sclerosis	2.37e-06	0.000104	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ALB—multiple sclerosis	2.35e-06	0.000103	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.3e-06	0.000101	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—STAT3—multiple sclerosis	2.2e-06	9.63e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—BCHE—multiple sclerosis	2.17e-06	9.52e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—APOE—multiple sclerosis	2.17e-06	9.51e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—APOE—multiple sclerosis	2.05e-06	8.98e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MYC—multiple sclerosis	2.04e-06	8.94e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TGFB1—multiple sclerosis	2.03e-06	8.92e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MAPK1—multiple sclerosis	2e-06	8.75e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—POMC—multiple sclerosis	1.86e-06	8.17e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—POMC—multiple sclerosis	1.76e-06	7.72e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ALB—multiple sclerosis	1.7e-06	7.45e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.68e-06	7.35e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—APOE—multiple sclerosis	1.64e-06	7.18e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ALB—multiple sclerosis	1.6e-06	7.04e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—IL6—multiple sclerosis	1.53e-06	6.72e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—POMC—multiple sclerosis	1.41e-06	6.16e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—APOE—multiple sclerosis	1.31e-06	5.73e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ALB—multiple sclerosis	1.28e-06	5.62e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—POMC—multiple sclerosis	1.12e-06	4.92e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ALB—multiple sclerosis	1.02e-06	4.49e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—APOE—multiple sclerosis	1.01e-06	4.42e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—POMC—multiple sclerosis	8.66e-07	3.8e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ALB—multiple sclerosis	7.9e-07	3.46e-05	CbGpPWpGaD
